Frontotemporal dementia and tauopathy
- PMID: 11898551
- DOI: 10.1007/s11910-001-0100-0
Frontotemporal dementia and tauopathy
Abstract
The presence of abundant neurofibrillary lesions made of hyperphosphorylated tau proteins is the characteristic neuropathology of a subset of neurodegenerative disorders classified as "tauopathies." The discovery of mutations in the tau gene in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) constitutes convincing evidence that tau proteins play a key role in the pathogenesis of neurodegenerative disorders. Moreover, it now is known that the most common form of sporadic frontotemporal dementia (FTD), which is characterized by frontotemporal neuron loss, gliosis, and microvacuolar change, also is a tauopathy caused by a loss of tau protein expression. Thus, these discoveries have begun to change the classification and the neuropathologic diagnosis of FTD and tauopathies, as well as current understanding of the disease mechanisms underlying them. Although transgenic mice expressing wild-type human tau or variants thereof with an FTDP-17 mutation result in tau pathologies and brain degeneration similar to that seen in human tauopathies, the precise mechanisms leading to the onset and progression of neurodegenerative disorders remain incompletely understood. Here, we review current understanding of human neurodegenerative tauopathies and prospects for translative recent insights about these into therapeutic interventions to prevent or ameliorate them.
Similar articles
-
Frequency of tau mutations in familial and sporadic frontotemporal dementia and other tauopathies.J Neurol. 2004 Sep;251(9):1098-104. doi: 10.1007/s00415-004-0489-x. J Neurol. 2004. PMID: 15372253
-
Studying tauopathies in Drosophila: A fruitful model.Exp Neurol. 2015 Dec;274(Pt A):52-7. doi: 10.1016/j.expneurol.2015.03.029. Epub 2015 Apr 7. Exp Neurol. 2015. PMID: 25862286 Review.
-
Neurodegenerative tauopathies.Annu Rev Neurosci. 2001;24:1121-59. doi: 10.1146/annurev.neuro.24.1.1121. Annu Rev Neurosci. 2001. PMID: 11520930 Review.
-
Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies.Brain. 2018 Feb 1;141(2):521-534. doi: 10.1093/brain/awx328. Brain. 2018. PMID: 29253099 Free PMC article.
-
The neuropathological spectrum of neurodegenerative tauopathies.IUBMB Life. 2003 Jun;55(6):299-305. doi: 10.1080/1521654032000114348. IUBMB Life. 2003. PMID: 12938731 Review.
Cited by
-
An individualized approach to treatment for alzheimer's disease, pick's disease, and other dementias.Am J Alzheimers Dis Other Demen. 2006 Oct-Nov;21(5):354-9. doi: 10.1177/1533317506292372. Am J Alzheimers Dis Other Demen. 2006. PMID: 17062555 Free PMC article. Review.
-
P301S-hTau acetylates KEAP1 to trigger synaptic toxicity via inhibiting NRF2/ARE pathway: A novel mechanism underlying hTau-induced synaptic toxicities.Clin Transl Med. 2022 Aug;12(8):e1003. doi: 10.1002/ctm2.1003. Clin Transl Med. 2022. PMID: 35917404 Free PMC article.
-
Transgenic mouse models of Alzheimer disease: developing a better model as a tool for therapeutic interventions.Curr Pharm Des. 2012;18(8):1131-47. doi: 10.2174/138161212799315786. Curr Pharm Des. 2012. PMID: 22288400 Free PMC article. Review.
-
A critical appraisal of the pathogenic protein spread hypothesis of neurodegeneration.Nat Rev Neurosci. 2016 Apr;17(4):251-60. doi: 10.1038/nrn.2016.13. Nat Rev Neurosci. 2016. PMID: 26988744 Free PMC article. Review.
-
The frontotemporal dementia mutation R406W blocks tau's interaction with the membrane in an annexin A2-dependent manner.J Cell Biol. 2011 Feb 21;192(4):647-61. doi: 10.1083/jcb.201007161. J Cell Biol. 2011. PMID: 21339331 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical